TOUYUN BIOTECH (01332) plans to issue 123 million shares at a discount of approximately 18.67%, raising about HKD 14.99 million net.

Touyun Biopharmaceutical (01332) announced that on August 25, 2026, the company intends to allocate and issue 123 million new shares to the subscriber Mr. Peng Yi, representing approximately 4.38% of the company's issued share capital as of the date of this announcement and approximately 4.20% of the issued share capital enlarged by the allocation and issuance of the subscribed shares. The subscription price is HK$0.122 per share, which reflects a discount of about 18.67% compared to the closing price of HK$0.150 per share on August 25. The total amount of funds raised from the subscription and the net amount of funds raised are HK$15.06 million and HK$14.99 million, respectively. The group intends to use the net proceeds for the general working capital of the group.